Stock listing
NASDAQ:TOI The Oncology Institute, Inc. Stock
Home listing (NASDAQ) of The Oncology Institute, Inc.
Follow The Oncology Institute, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TOI
$3.18 USD -0.02 (-0.6%)
Close on Nov 19, 2026 · Data provided by Twelve Data
- Day range
- $3.17 – $3.44 USDNov 19, 2026
- Volume
- 2.81M sharesNov 19, 2026
- Market cap
- $319.5M USDAt the close on Nov 19, 2026 · price × 100.5M shares outstanding
- 52-week range
- $2.32 – $7.13 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $12.07M USDMedian day 1.25M shares · last 3 months, Aug 19, 2026 – Nov 19, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TOI · Home | $3.18 USD | -0.02 (-0.6%) | 2,812,613 | $3.25 | $3.44 | $3.165 | $3.20 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · NASDAQ:TOI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.18 | -0.02 | -0.6% | $3.25 | $3.44 | $3.165 | 2,812,613 | |
| $3.20 | -0.20 | -5.9% | $3.38 | $3.46 | $3.13 | 4,680,581 | |
| $3.40 | -0.14 | -4.0% | $3.61 | $3.669 | $3.355 | 4,010,843 | |
| $3.54 | +0.04 | +1.1% | $3.52 | $3.80 | $3.51 | 7,246,807 | |
| $3.50 | -0.25 | -6.7% | $3.76 | $3.775 | $3.30 | 22,268,194 | |
| $3.75 | -0.45 | -10.7% | $4.10 | $4.24 | $3.67 | 6,548,786 | |
| $4.20 | -0.14 | -3.2% | $4.81 | $4.81 | $4.16 | 2,978,900 | |
| $4.34 | +0.34 | +8.5% | $3.97 | $4.435 | $3.97 | 6,453,945 | |
| $4.00 | +0.38 | +10.5% | $3.98 | $4.53 | $3.50 | 8,837,655 | |
| $3.62 | -3.08 | -46.0% | $6.06 | $6.43 | $3.351 | 23,917,528 | |
| $6.70 | -0.24 | -3.5% | $6.88 | $7.015 | $6.56 | 2,081,124 | |
| $6.94 | +0.60 | +9.5% | $6.44 | $7.04 | $6.41 | 1,688,231 | |
| $6.34 | +0.09 | +1.4% | $6.25 | $6.365 | $6.19 | 1,013,342 | |
| $6.25 | -0.28 | -4.3% | $6.53 | $6.53 | $6.23 | 1,461,241 | |
| $6.53 | -0.12 | -1.8% | $6.49 | $6.69 | $6.35 | 1,422,308 | |
| $6.65 | +0.01 | +0.2% | $6.65 | $6.85 | $6.58 | 1,107,731 | |
| $6.64 | +0.05 | +0.8% | $6.62 | $6.79 | $6.50 | 1,153,441 | |
| $6.59 | +0.30 | +4.8% | $6.28 | $6.625 | $6.26 | 1,314,780 | |
| $6.29 | -0.42 | -6.3% | $6.73 | $6.81 | $6.19 | 1,866,248 | |
| $6.71 | -0.20 | -2.9% | $6.92 | $6.96 | $6.66 | 1,055,869 | |
| $6.91 | +0.08 | +1.2% | $6.755 | $6.96 | $6.69 | 871,697 | |
| $6.83 | +0.20 | +3.0% | $6.67 | $6.95 | $6.62 | 1,454,070 | |
| $6.63 | +0.17 | +2.6% | $6.48 | $6.86 | $6.39 | 1,097,354 | |
| $6.46 | +0.03 | +0.5% | $6.55 | $6.65 | $6.43 | 983,046 | |
| $6.43 | -0.48 | -6.9% | $6.85 | $6.90 | $6.34 | 1,773,693 | |
| $6.91 | +0.40 | +6.1% | $6.49 | $6.935 | $6.36 | 1,186,752 | |
| $6.51 | -0.19 | -2.8% | $6.68 | $6.75 | $6.415 | 1,338,683 | |
| $6.70 | -0.22 | -3.2% | $6.93 | $7.00 | $6.68 | 1,277,918 | |
| $6.92 | +0.29 | +4.4% | $6.60 | $6.975 | $6.60 | 965,456 | |
| $6.63 | +0.45 | +7.3% | $6.18 | $6.84 | $6.18 | 1,848,350 | |
| $6.18 | -0.25 | -3.9% | $6.39 | $6.41 | $6.125 | 1,255,980 | |
| $6.43 | -0.15 | -2.3% | $6.50 | $6.79 | $6.375 | 949,109 | |
| $6.58 | +0.28 | +4.4% | $6.38 | $6.64 | $6.355 | 985,796 | |
| $6.30 | -0.05 | -0.8% | $6.33 | $6.365 | $6.205 | 1,336,776 | |
| $6.35 | +0.135 | +2.2% | $6.36 | $6.38 | $6.22 | 793,879 | |
| $6.215 | -0.105 | -1.7% | $6.30 | $6.43 | $6.175 | 994,195 | |
| $6.32 | -0.19 | -2.9% | $6.51 | $6.59 | $6.315 | 946,918 | |
| $6.51 | -0.13 | -2.0% | $6.73 | $6.73 | $6.34 | 972,913 | |
| $6.64 | -0.02 | -0.3% | $6.59 | $6.79 | $6.48 | 919,193 | |
| $6.66 | +0.15 | +2.3% | $6.50 | $6.86 | $6.41 | 1,127,177 | |
| $6.51 | -0.31 | -4.5% | $6.72 | $6.946 | $6.375 | 1,762,590 | |
| $6.82 | -0.23 | -3.3% | $7.00 | $7.00 | $6.605 | 1,115,380 | |
| $7.05 | +0.22 | +3.2% | $6.92 | $7.065 | $6.765 | 1,050,937 | |
| $6.83 | -0.13 | -1.9% | $6.98 | $7.047 | $6.73 | 1,253,247 | |
| $6.96 | +0.33 | +5.0% | $6.62 | $7.13 | $6.62 | 3,761,727 | |
| $6.63 | +0.10 | +1.5% | $6.66 | $7.00 | $6.52 | 3,219,320 | |
| $6.53 | +0.16 | +2.5% | $6.42 | $6.69 | $6.375 | 1,388,437 | |
| $6.37 | -0.15 | -2.3% | $6.42 | $6.571 | $6.31 | 1,173,934 | |
| $6.52 | +0.35 | +5.7% | $6.16 | $6.697 | $6.12 | 1,504,218 | |
| $6.17 | -0.03 | -0.5% | $6.28 | $6.41 | $6.105 | 790,888 | |
| $6.20 | -0.09 | -1.4% | $6.17 | $6.50 | $6.135 | 680,023 | |
| $6.29 | -0.03 | -0.5% | $6.31 | $6.40 | $6.00 | 846,511 | |
| $6.32 | +0.39 | +6.6% | $5.86 | $6.475 | $5.85 | 1,776,326 | |
| $5.93 | -0.04 | -0.7% | $5.91 | $5.98 | $5.87 | 466,625 | |
| $5.97 | -0.12 | -2.0% | $6.09 | $6.11 | $5.811 | 660,924 | |
| $6.09 | +0.15 | +2.5% | $5.93 | $6.13 | $5.90 | 841,679 | |
| $5.94 | +0.03 | +0.5% | $5.91 | $6.18 | $5.903 | 947,280 | |
| $5.91 | -0.26 | -4.2% | $6.20 | $6.285 | $5.76 | 1,345,712 | |
| $6.17 | -0.17 | -2.7% | $6.34 | $6.41 | $6.10 | 960,696 | |
| $6.34 | -0.22 | -3.4% | $6.54 | $6.57 | $6.19 | 1,590,728 | |
| $6.56 | +0.26 | +4.1% | $6.21 | $6.685 | $6.15 | 1,219,102 | |
| $6.30 | +0.17 | +2.8% | $6.18 | $6.325 | $6.11 | 1,021,110 | |
| $6.13 | -0.335 | -5.2% | $6.43 | $6.43 | $6.095 | 1,228,998 | |
| $6.465 | -0.075 | -1.1% | $6.59 | $6.75 | $6.365 | 1,530,838 | |
| $6.54 | -0.12 | -1.8% | $6.66 | $6.80 | $6.40 | 1,172,757 | |
| $6.66 | +0.26 | +4.1% | $6.51 | $6.80 | $6.30 | 1,305,530 |
- Ticker
- NASDAQ:TOI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Jul 27, 2026
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Latest deck · Nov 12, 2026
Starling Oncology — Investor Presentation (November 2026)
Investor deck · 29 slides
Latest news
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Jul 27, 2026
Closed $5.19 (+4.2%) on Jul 27, 2026
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
Jul 7, 2026
Closed $5.80 (+6.6%) on Jul 7, 2026
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
May 26, 2026
Closed $4.59 (0.0%) on May 26, 2026
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
May 13, 2026
Closed $4.08 (+1.5%) on May 13, 2026
The Oncology Institute Reports First Quarter 2026 Financial Results
May 7, 2026
Closed $4.00 (-1.7%) on May 8, 2026
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
Apr 27, 2026
Closed $3.33 (+2.5%) on Apr 27, 2026
The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement
Apr 13, 2026
Closed $3.30 (+7.1%) on Apr 13, 2026
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings
Apr 10, 2026
Closed $3.30 (+7.1%) on Apr 13, 2026
The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
Apr 9, 2026
Closed $3.11 (+0.3%) on Apr 9, 2026
The Oncology Institute Names Minh Merchant Chief Legal Officer
Apr 6, 2026
Closed $3.21 (+2.9%) on Apr 6, 2026
The Oncology Institute, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 19 in the last 12 months · 120 in all · newest Jul 27, 2026 · oldest 2021
- Decks
- 17 decks · latest Nov 12, 2026
Where The Oncology Institute, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TOI · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TOI | BOATS | United States | USD |
Valuation
price Nov 19, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 1.59
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| The Oncology Institute, Inc. · NASDAQ:TOI | US$319.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.59 |
| PT Enseval Putera Megatrading Tbk · IDX:EPMT | US$353.0M | US$316.7M | 7.3× | 0.2× | 4.3× | 0.8× | 2.5% | 0.0× | n/a |
| Instituto de Diagnostico S.A. · BCS:INDISA | US$345.1M | US$396.4M | 27.8× | 1.4× | 16.7× | 1.6× | 4.4% | 0.3× | n/a |
| Optima Health PLC · LSE:OPT | US$342.9M | US$438.9M | 187× | 2.8× | 22.1× | 1.5× | 1.2% | 0.6× | n/a |
| Viemed Healthcare, Inc. · NASDAQ:VMD | US$324.5M | US$319.9M | 20.8× | 1.0× | 6.0× | 2.2× | 5.0% | 0.0× | 0.51 |
| Liaoning He Eye Hospital Group Co., Ltd. Class A · SZSE:301103 | US$324.5M | US$114.2M | 80.7× | 0.7× | n/a | 1.1× | 2.4% | 0.0× | n/a |
| Alpha IVF Group Bhd. · MYX:ALPHA | US$323.4M | US$289.0M | 24.9× | 6.0× | 13.9× | 7.5× | 26.8% | 0.0× | n/a |
| GoodRx Holdings, Inc. · NASDAQ:GDRX | US$313.0M | US$503.4M | 19.3× | 0.6× | 3.1× | 0.5× | 2.1% | 0.8× | 1.50 |
| Claritev Corporation · NYSE:CTEV | US$312.1M | US$4.95B | n/a | 4.9× | 34.3× | n/a | −27.1% | n/a | 2.50 |
| Hospital Mater Dei SA · BMFBOVESPA:MATD3 | US$290.6M | US$396.6M | 12.1× | 1.0× | 3.6× | 1.1× | 6.1% | 0.8× | n/a |
| InfuSystems Holdings, Inc. · AMEX:INFU | US$287.5M | US$300.9M | 30.4× | 2.1× | 11.1× | 4.5× | 6.5% | 0.3× | 0.82 |
| Median of the others | US$323.9M | US$358.1M | 24.9× | 1.2× | 11.1× | 1.5× | 3.4% | 0.3× | 1.16 |
Team and board
Officers
| Officer | Role |
|---|---|
| Daniel Virnich | Chief Executive Officer |
| Rob Carter | Chief Financial Officer |
| Dan Ayer | Regional President |
| Yale D. Podnos | Chief Medical Officer, President of Practice |
| Minh Merchant | Chief Legal Officer |
| Austin Lee | VP Accounting, Controller |
| Stephen Cella | Senior Vice President, Finance |
| Jeffrey Langsam | Chief Clinical Officer |
| Jordan McInerney | Chief Development Officer |
| Kiran Annavarapu | Regional President |
| Kristin England | Chief Administrative Officer |
| Nolan Mariano | Chief People Officer |
| Rakesh Panda | Chief Information Officer |
| Stacy Constantine | Regional President |
Board
| Director | Role |
|---|---|
| Kim Tzoumakas | Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Starling Oncology — Investor Presentation (November 2026) | Investor deck | 29 slides | Nov 12, 2026 |
| Starling Oncology — Investor Presentation (September 2026) | Investor deck | 28 slides | September 2026 |
| Oncology Institute — Investor Presentation (March 2026) | Investor deck | 27 slides | Mar 13, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 27 slides | March 2026 |
| Oncology Institute — Q3 2025 Earnings Presentation | Earnings | 26 slides | Nov 14, 2025 |
| Oncology Institute — Investor Presentation (May 2025) | Investor deck | 21 slides | May 19, 2025 |
| Investor Presentation (May 2025) | Investor deck | 21 slides | May 2025 |
| Oncology Institute — Investor Presentation (March 2025) | Investor deck | 21 slides | Mar 24, 2025 |
| Oncology Institute — Investor Presentation (April 2024) | Investor deck | 21 slides | Apr 3, 2024 |
| Oncology Institute — Investor Presentation (August 2023) | Investor deck | 22 slides | Aug 10, 2023 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Oncology Institute — Investor Presentation (March 2023) | Investor deck | 32 slides | Mar 27, 2023 |
| Oncology Institute — Investor Presentation (November 2022) | Investor deck | 32 slides | Nov 15, 2022 |
| Oncology Institute — Investor Presentation (August 2022) | Investor deck | 31 slides | Aug 16, 2022 |
| Oncology Institute — Investor Presentation (March 2022) | Investor deck | 23 slides | Mar 18, 2022 |
| Oncology Institute — FY2021 Earnings Presentation | Earnings | 30 slides | Mar 11, 2022 |
| DFP Healthcare Acquisitions — SPAC Merger (October 2021) | SPAC merger | 42 slides | Oct 12, 2021 |
| DFP Healthcare Acquisitions — SPAC Merger (June 2021) | SPAC merger | 44 slides | Jun 28, 2021 |
Cap table
Built by 6ix from The Oncology Institute, Inc.’s releases
- Common shares
- 100,468,979
- Fully diluted
- 100,468,979
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 100,468,979 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 100,468,979 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Stolper Other companies: RadNet, Inc. (Executive Vice President and Chief Financial Officer · Since at least Jan 4, 2021); Surgalign Holdings Inc (Director · Feb 1, 2021 – Aug 15, 2022 · Past); Coherus Oncology, Inc. (Director · Jan 5, 2021 – Jun 3, 2024 · Past) | Director · Since at least Jan 2, 2026 |
| Kimberly Jo Tzoumakas Other companies: Coherus Oncology, Inc. (Director · Jul 30, 2020 – Jun 3, 2024 · Past); SeaSpine Holdings Corp (Director · Feb 19, 2019 – Jun 3, 2020 · Past) | Director · Since at least Feb 23, 2026 |
| Mohit Kaushal Other companies: Oak Street Health Inc (Director · Aug 5, 2020 – May 2, 2023 · Past); AdaptHealth Corp. (Director · Nov 8, 2019 – Nov 8, 2019 · Past) | Director · Since at least Nov 12, 2021 |
| Anne McGeorge Other companies: Dianthus Therapeutics, Inc. (Director · Since at least Jun 20, 2019) | Director · Since at least Nov 12, 2021 |
| Maeve O'Meara Other companies: Castlight Health Inc (Chief Executive Officer, Director · Jun 8, 2018 – Jan 12, 2022 · Past) | Director · Nov 12, 2021 – Dec 26, 2023 · Past |
| Mihir Shah Other companies: Astrana Health Inc. (Chief Financial Officer · Jul 21, 2016 – Jan 15, 2018 · Past) | Chief Financial Officer · May 19, 2022 – May 21, 2024 · Past |
| Ravi Sarin Other companies: American Oncology Network, Inc. (BOARD MEMBER · Since at least Sep 20, 2023) | Director · Nov 12, 2021 – Mar 17, 2023 · Past |
| Austin Lee | VP Accounting, Controller · Since at least Nov 5, 2026 |
| Brad Hively | Director · Since at least Jul 27, 2026 |
| Dan Ayer | Regional President · Since at least Nov 4, 2026 |
All 31 people
| Person | Seat |
|---|---|
| Daniel Virnich | Chief Executive Officer · Since at least Nov 12, 2021 |
| Diona Simoneit | Chief Accounting Officer · Nov 15, 2022 – Nov 17, 2022 · Past |
| Gabriel Ling | Director · Since at least Nov 18, 2025 |
| Jeffrey Langsam | Chief Clinical Officer · Since at least May 13, 2025 |
| Jordan McInerney | Chief Development Officer · Since at least Nov 5, 2026 |
| Karen Marie Johnson | Director · Since at least Nov 12, 2021 |
| Kim Tzoumakas | Director · Since at least Feb 23, 2026 |
| Kiran Annavarapu | Regional President · Since at least Nov 5, 2026 |
| Kristin England | Chief Administrative Officer · Since at least Jul 7, 2025 |
| Mark L Pacala | Director · Since at least Sep 21, 2022 |
| Matthew P Miller | Chief Operating Officer · Mar 15, 2022 – Mar 17, 2023 · Past |
| Minh Merchant | Chief Legal Officer · Since at least Apr 6, 2026 |
| Nolan Mariano | Chief People Officer · Since at least Jan 9, 2026 |
| Rakesh Panda | Chief Information Officer · Since at least Jan 9, 2026 |
| Richard A Barasch | Director · Since at least Jun 17, 2025 |
| Rob Carter | Chief Financial Officer · Since at least May 13, 2026 |
| Robert Ross Carter | Chief Financial Officer · Since at least Mar 27, 2026 |
| Scott Dalgleish | Chief Financial Officer · Nov 12, 2021 – Mar 21, 2022 · Past |
| Stacy Constantine | Regional President · Since at least Nov 5, 2026 |
| Stephen Cella | Senior Vice President, Finance · Since at least Nov 5, 2026 |
| Yale D. Podnos | Chief Medical Officer, President of Practice · Since at least Nov 12, 2021 |
Log in to ask 6ix AI your own questions about The Oncology Institute, Inc.